Pulmonary Essay

Hayflinger, D. C., Rosenberg, D. M., & Hunsche E., Burden of illness in idiopathic pulmonary fibrosis, (2012). Idiopathic pulmonary fibrosis (IPF) is a highly morbid disease of aging in which the incidence has been reported to be climbing, with no widely accepted therapy in the U.S other than a lung transplant. Harold et al., 2012). The purpose of this study was to describe the burdens that patients with idiopathic pulmonary fibrosis (IPF) encounter, such as comorbidites, healthcare utilization, and associated

Pulmonary Embolism a Silent killer Pulmonary Embolism is a life-threatening condition that has most serious manifestation of venous thromboembolism that is leading cause of sudden death. “With massive pulmonary embolism (PE) being the first or second leading cause of unexpected death in adults, protection against PE is critical in appropriately selected patients” (Georgiou, Katz, Ganson, Eng, & Hon, 2015). How does this effect the nursing? If Pulmonary embolism is suspected, nurses goal is to halt

Pulmonary rehabilitation has been clearly demonstrated to reduce dyspnea, increase exercise capacity, and improve quality of life in individuals with chronic obstructive pulmonary disease. There has been an increased evidence of the effcicay of pulmonary rehabilitation for COPD and other related respiratory diseases such as interstitial lung disease, bronchiectasis, cystic fibrosis, asthma, pulmonary hypertension, lung cancer, lung volume reduction surgery, and lung transplantation (Spruit et al

Case study The case study relates to Mr Brown, who diagnosed with acute pulmonary oedema secondary to acute renal failure, due to excessive use of opioids. The assignment will address Mr Brown’s initial presentation and assessment, relevant past history, medications as well as the current assessment finding that had him admitted to intensive care unit. Briefly discussing the patients’ pathology results scans and as well as drug treatments to correct electrolyte imbalances. Furthermore discuss the

Chronic Obstructive pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) is not one single disease but an umbrella term used to describe chronic lung diseases that cause limitations in the air flow. According to the latest World Health Organization (WHO) estimates (2004), currently 64 million people have COPD and 3 million died of COPD, WHO predicts that COPD will become the third leading cause of death worldwide by 2030. Common causes of COPD: • Inhaling pollutants: Smoking

Nursing Teaching Paper Synopsis All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010). The risk factors of COPD

COPD Case Study Chronic obstructive pulmonary disease (COPD) is an interchangeable phrase used to describe respiratory diseases characterized by airway obstruction. COPD is now a well-known and serious chronic disease, killing many and affecting a mass number of people per year. COPD is a result in restricted (obstructed) airflow in the lungs. Obstructive diseases include bronchitis, in which inflammation causes chronic bronchial secretions and narrowing of the bronchi and emphysema a permanent

Abstract Pulmonary Fibrosis is a serious disease that claims and terrorizes thousands of lives and families. Due to severity of the disease two Senators have decided to introduce an Act that is dedicated to this horrifying disease (the Pulmonary Fibrosis Research Enhancement Act (PFREA)). After the onset of symptoms of pulmonary fibrosis, a person has about 5 years of lifespan, that’s taking in consideration treatment that will be given to the patient. About 30 present of patient that receive treatment

Pulmonary Case Study Analysis and Care Plan Chronic obstructive pulmonary disease (COPD) is most prevalent in the older adult and smokers. It is the third leading cause of death in the United States and affects 329 million people worldwide. The disease also carries a burden on the economy with an estimated cost of $29.5 billion annually for treating exacerbations (Hattab, Alhassan, Balaan, Lega, & Singh, 2016). It is defined as the limitation of airflow within the airway and lungs secondary to

Surfactant Replacement Therapy and the Affects on RDS and Other Pulmonary Disorders Jacquelyn M. Wood Grossmont Community College 2015 INTRODUCTION As a newborn makes their entrance to this world from intrauterine life all should go smoothly. The newborn is delivered and is stimulated to breathe and then is followed by inspirations, followed by a cry showing a successful arrival to this world, but not all deliveries go as planned. There are diseases of the respiratory system. The most